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ABSTRACT
Background and aims There is limited evidence on what shapes amphetamine-type stimulant (ATS) use trajectories.
This systematic narrative review and qualitative synthesis aimed to identify individual, social and environmental inﬂu-
ences shaping key phases in the ATS use trajectory: initiation, continuation, increase/relapse and decrease/abstinence.
Methods MEDLINE, PsycINFO, EMBASE, and PROQUEST (social science premium collection) were searched from
2000 to 2018. Studies of any qualitative design were eligible for inclusion. Extracted datawere analysed according to four
key phases within drug pathways, and then cross-analysed for individual, social and environmental inﬂuences.
Results Forty-four papers based on 39unique studies were included, reporting the views of 1879ATS users. Participants
were aged 14–58 years, from varied socio-economic and demographic groups, and located in North America, Europe,
Australasia and South East Asia. Reasons for initiation included: to boost performance at work and in sexual relationships,
promote a sense of social ‘belonging’ and helpmanage stress. Similar reasons motivated continued use, combined with the
challenge of managing withdrawal effects in long-term users. Increased tolerance and/or experiencing a critical life event
contributed to an increase in use. Reasons for decrease focused on: increased awareness of the negative health impacts of
long-term use, disconnecting from social networks or relationships and ﬁnancial instability. Conclusions Amphetamine-
type stimulant users are a highly diverse population, and their drug use careers are shaped by a complex dynamic of
individual, social and environmental factors. Tailored, joined-up interventions are needed to address users’ overlapping
economic, health and social care needs in order to support long-term abstinence.
Keywords Amphetamine-related disorders, amphetamine-type stimulants, drug use trajectory, life course, qualitative
synthesis, systematic review.
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INTRODUCTION
Amphetamine-type stimulants (ATS), such as amphet-
amine, methamphetamine and 3,4-methylenedioxy-
methamphetamine (MDMA or ecstasy), are the second
most commonly used class of illicit drugs globally [1]. A
decline in levels of use reported at the start of this decade
in some regions of the world has been reversed in recent
years, with a pronounced increase in East and South East
Asia [2]. The United Nations Ofﬁce of Drugs and Crime
report that world-wide quantities of ATS seized doubled
between 2010 and 2015, with methamphetamine ac-
counting for 61–80% [2]. Alongside more traditional
ATS, there has also been a rise in the number of
stimulant-type novel psychoactive substances (NPS) in
global drug markets, including synthetic cathinones such
as benzylpiperazine (BZP) and mephedrone [3]. Increasing
rates of methylphenidate (MPH) abuse have also been re-
ported, often by students seeking to enhance their cogni-
tive performance [4–6].
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Methamphetamine use at dependent levels is associ-
ated with multiple comorbidities, including HIV infection,
hepatitis, cardiac effects, cognitive dysfunction and prom-
inent psychiatric consequences, such as psychosis [7,8].
Although MDMA is often viewed as a recreational drug,
prolonged use is associated with neurological dysfunction
and depression [9]. Additional societal costs identiﬁed
with ATS abuse include premature death, crime, lost pro-
ductivity, environmental damage, disruption of family life
and infectious disease [7,10,11]. However, few treatment
options exist [12]. There is currently no effective phar-
macotherapy for methamphetamine- or amphetamine-
type stimulant dependency [13]. While there is some ev-
idence of efﬁcacy for psychosocial therapies [14–16],
their real-world impact has been limited by poor reten-
tion rates and treatment adherence among ATS users
[17], with high rates of relapse [18]. Given the adverse
and often irreversible impacts of repeated ATS use, with
early age of onset recognized as one of the best predictors
of future substance abuse and dependence [12], preven-
tion is also key. However, again, few effective preventative
intervention options exist [19,20].
Complex and inter-related factors contribute to both
an individual’s drug use, and their capacity to engage
with, and beneﬁt from, preventive advice and/or treat-
ment [21,22]. In contrast to epidemiological methods
or effectiveness studies, qualitative research allows us
to explore the attitudes and experiences that shape sub-
stance users’ behaviour at key moments of change
(phases), while recognizing that these practices are em-
bedded within a speciﬁc socio-cultural space and time
[23,24]. Such knowledge is critical to the development
of more effective prevention and treatment for problem
ATS use [25], not least as there is evidence that inter-
ventions are more likely to be effective when individuals
feel positive about and satisﬁed with the support that
they receive [26]. This review aimed to synthesize qual-
itative data to understand which individual, social and
environmental inﬂuences shape critical phases in ATS
users’ drug careers [27–29].





We searched MEDLINE, PsycINFO, EMBASE and
PROQUEST (social science premium collection) for peer-
reviewed qualitative studies (including the qualitative ele-
ments of mixed methods research) conducted in any set-
ting which explored the views of ATS users aged 13+ on
which factors have shaped their drug use careers. Due to
the rapidly changing ATS drug scene [2], we focused on lit-
erature published from 1 January 2000 to 13March 2018
(see Table 1 for detailed inclusion and exclusion criteria).
The search strategy was split into ﬁve core concepts in ac-
cordance with the SPIDER tool (Sample, Phenomenon of
Interest, Design, Evaluation and Research type) (see
Table 2) [30]. Terms were coupled with relevant
MeSH/thesaurus terms and truncated as appropriate, with
variant spellings used. In acknowledgement of the difﬁ-
culty of identifying relevant qualitative research [31], we
also hand-searched selected journals, reviewed relevant
websites and checked the reference lists of included studies.
Search results were downloaded to a bibliographic soft-
ware program (EndNote X7) and de-duplicated. Titles and
abstracts were screened independently and full texts then
similarly reviewed to identify eligible studies. Any disagree-
ments were resolved by discussion or in consultation with
another team member. A structured data abstraction form
was used to capture: bibliographic details; design and
methodology; aim and objectives; and summary ﬁndings.
Quality assessment
Included literature were quality assessed using the Critical
Appraisal Skills Programme (CASP) Research Checklist
[32], which evaluates studies on the basis of: (1) clarity of
research aims; (2) appropriateness of qualitative
Table 1 Inclusion and exclusion criteria.
Inclusion criteria
Study type: Any qualitative design including: ethnographies; phenomenological or grounded theory-based studies;
participatory action research; and the qualitative elements of mixed methods studies
Participants: ATS users aged 13 years and over
Setting: Any setting
Focus of studies: Views and experiences of ATS users on which factors have shaped their drug use careers
Publication date: Studies published from 2000 onwards
Exclusion criteria
• Studies that used structured questionnaires as the sole method of data collection.
• Studies that focus on polysubstance use unless ATS relevant data could be accessed.
ATS = amphetamine-type stimulant.
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methodology; (3) appropriateness of research design; (4) ap-
propriateness of the recruitment strategy; (5) data collection
method; (6) consideration of researcher–participant rela-
tionship: (7) consideration of ethical issues, (8) rigour of data
analysis, (9) clarity of ﬁndings and (10) overall value, rele-
vance and impact of the research. Yes/no responses to the
ﬁrst nine questions were used to inform a grading system:
0–4 positive responses elicited a low-quality rating; 5–7 a
moderate-quality rating; and 8–9 a high-quality rating.
Studies were not excluded on the basis of quality, as poor
reporting is not necessarily suggestive of poorly conducted
research [33], but were retained on the basis of whether
they contributed valuable or novel data to the review.
Data synthesis
Data synthesis was based on Thomas and Harden’s the-
matic method [34]. Content was downloaded into qualita-
tive data management software (Nvivo version 10), and
line-by-line coding of the meaning and content of each
studywas conducted independently by two reviewers. Data
reported in multiple papers but relating to the same indi-
vidual study were coded separately to maximize thematic
yield. Next, these codes were compared and contrasted by
the review team, and a hierarchy of descriptive themes
and subthemes was identiﬁed. Finally, we returned to the
original review question, cross-examining these initial de-
scriptive themes for individual (such as personality traits,
beliefs, mental health and resilience), social (such as
friends, family and relationships, education and employ-
ment) and environmental (such as policy, legislation, phys-
ical place and space) factors relating to the critical phases
of interest: initiation, continuation, increase/relapse and
decrease/abstinence. This approach avoided forcing the ev-
idence into pre-determined categories, and encouraged a
reﬂective and iterative approach to data synthesis.
RESULTS
Thirty-nine individual studies were included, reported in
44 papers, and covering the views of 1879 ATS users
[22,24,35–76] (see Fig. 1, Table 3).
Study characteristics
Participants were aged between 14 and 58 years. Six
studies (eight papers) included only females
[24,35,42,43,53,56,73,74] and eight only males
[39,44,45,48,59,64,65,72], ﬁve of which focused on
men who have sex with men (MSM) [39,48,59,65,72].
Twenty-ﬁve included both genders (28 papers)
[22,36–38,40,41,46,47,49–52,54,55,57,58,60–63,66–
71,75,76]. Methodologies employed included in-depth
interviews [22,35,37,38,46–48,50,52–59,61,62,64–
73,75], ethnographies [40,45,49,52,63,74], focus
groups [45,59,60,72] and documentary analysis [76].
Twenty-three studies (27 papers) originated in North
America [22,24,35–38,40–44,47,49,50,54,57,60,63–
66,71,73–76], ﬁve in Europe (six papers)
[39,53,55,58,61,62,69,70], four in Australia
[46,48,52,67] and six in South East Asia
[45,51,56,59,68,72]. All participants were polysubstance
users. Three studies (four papers) focused speciﬁcally on
NPS use [39,61,62,75]. Six studies (eight papers) exam-
ined abuse of prescriptionmedication for conditions such
as attention deﬁcit hyperactive disorder (ADHD)
[24,38,42–44,52,55,57]. Of the 39 studies quality
assessed: two were rated as low- [40,56] due to lack of
information about recruitment, ethical considerations
and/or ﬁndings; 27 moderate- (32 papers) [24,35–
39,41,42,44–50,52–54,57–63,65–67,70,71,75,76]; and
10 high-quality [22,43,51,55,64,68,69,72–74].
Table 2 Search strategy.
SPIDER concept Search terms
S - Sample: sdult and adolescent
ATS users
Amphetamine sulphate OR 3,4-Methylenedioxymethamphetamine OR Methylamphetamine OR
Crystal Methylamphetamine OR Crystal Meth OR Mephedrone OR Cathinone OR MDMA OR
Ecstasy OR stimulant* OR Amphetamine OR legal high OR novel psychoactive substance OR
NPS OR Ritalin
PI - Phenomenon of interest:
pathways of stimulant use over
the life course
Life course OR turning point OR trajectory OR life event OR pathway OR transition OR recovery
OR drug career* OR maturing out OR trigger OR desistance OR route* in OR route* out OR
treatment OR drug services or milestone* OR change OR decreas* OR increas* OR initiat*
D - Design: qualitative research Interview OR grounded theory OR ethnography OR interpretative phenomenological
analysis OR phenomenology OR focus group OR content analysis OR thematic analysis OR
constant comparative OR participant observation
E - Evaluation: experience perceive OR perception OR perspective OR view OR experience OR attitude OR belief OR
opinion OR feel OR know OR understand
R - Research type: qualitative
and mixed methods
Qualitative OR qualitative analysis OR qualitative research OR mixed methods
ATS = amphetamine-type stimulant.
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Themes by phase and inﬂuencing factor
Synthesized data are described narratively below, with the
overall coding of themes summarized in Fig. 2. Speciﬁc ATS
phases, inﬂuencing factors and illustrative quotes are pro-
vided in Table 4.
Initiation
Individual factors
Fifteen studies (16 papers) identiﬁed personal characteris-
tics such as curiosity and propensity for experimentation
as inﬂuencing the initiation of ATS use
[24,40,41,46,47,50,56–58,60,61,65,68–70,75]. Van
Hout & Brennan examined mephedrone use in Ireland be-
fore the introduction of legislation banning the sale of all
psychoactive drugs [69]. They highlighted the potential
for individuals open to experimentation and impulsivity
to start using ATS, particularly in recreational settings.
Sherman et al. examined ATS use in rural northern
Thailand [68], and also found that curiosity about the ef-
fects of ATS spurred on usage, often supported by a hedo-
nistic attitude towards perceived risks. Four studies
identiﬁed enhancement of sex as a factor in ATS initiation
[39,47,56,65], predominantly among MSM communities
[39,47,65]
Ten (12 papers) studies identiﬁed self-management of
mental health and trauma as a factor motivating initiation
of ATS, mostly in methamphetamine users
[22,24,40,42,49,50,53,60,63,68,71,74]. Early traumatic
experiences were found to prompt initiation of ATS use
among female inmates in a North American prison [42].
Methamphetamine-addicted mothers reported taking ATS
to manage low mood and loneliness, and to boost energy
[53]. A further study of methamphetamine use by street-
entrenched young adults in Vancouver found that ATS ini-
tiation was linked to self-management of depression, anxi-
ety, undiagnosed attention deﬁcit disorder and
schizophrenia [49].
Social factors
Family, friendships and intimate relationships with other
ATS users was a common social factor contributing to ini-
tiation, mentioned by 23 studies (24 papers)
[22,24,37,38,40–42,46–48,50,53,57,58,60–65,67–
69,71,74]. Initiation of ATS use by dangerous sport enthu-
siasts helped to cement friendships and facilitate identity
formation as a risk taker [58]. Social proximity to drug
dealers was also highlighted as encouraging ATS initiation:
Von Mayrhauser et al. report that a quarter of their partic-
ipants were introduced to ATS by dealers [71]. However, in
Eiserman et al.’s study of ecstasy use among young adults
in an urban setting, family and friends were more inﬂuen-
tial [47].
Using ATS, and in particular methamphetamine, to
enhance work-place performance was a further
common theme, reported in eight studies
Figure 1 Flow diagram [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
27

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































28 Amy O’Donnell et al.







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































30 Amy O’Donnell et al.
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































32 Amy O’Donnell et al.





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































34 Amy O’Donnell et al.





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































36 Amy O’Donnell et al.
© 2018 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. Addiction, 114, 24–47
[22,37,38,40,56,64,68,71]. Participants in Ojeda et al.’s
study of Mexican men being deported from the United
States used ATS to help them manage exhaustion when
working long hours [64]. A similar message emerged in re-
search from Boeri et al. examining the trajectories of current
and ex-methamphetamine users in a North American sub-
urb [22]. Participants described being encouraged to use
ATS by co-workers to increase energy levels. In addition to
enhancing performance, Sherman et al.’s study in Thailand
linked ATS initiation to hunger reduction at work [68].
Environmental factors
Thirteen studies found that frequent exposure to
ATS within certain settings triggered use initiation
[22,24,37,40,41,45–50,55–59,65–68], particularly
house parties and nightclubs [40,58,62–64]. As Bahora
et al.’s examination of recreational ecstasy use in North
America underlines, when ATS are accessible, available and
normalized in sociable spaces, likelihoodof initiationhasbeen
found to increase [36], a ﬁnding echoed in a study of stimu-
lant type NPS in Ireland prior to legislative control [61].
Continuation
Individual factors
Sexual enhancement was a key reason for continued
methamphetamine use. This relates to boosting sexual
pleasure in conventional intimate relationships [71], as
well as functional sexual performance and offsetting of as-
sociated low mood in both MSM and female sex workers
[56,72]. Indeed, coping with ongoing mental health needs
was a common theme identiﬁed elsewhere
[29,42,43,46,47,49,50,57,67,68,70–72,74], particularly
among methamphetamine users. For example, Fast et al.’s
study of street-entrenched young people in Canada re-
ported that many users were self-medicating to manage
depression and the stress of living in severely deprived cir-
cumstances [49].
Eight studies focused on the link between sustained ATS
use and a perception of being in control [22,36,41,49,57–
59,67]. Bahora et al. found that long-term ecstasy users did
not identify any adverse impacts on their day-to-day life
and believed that ATS were not addictive [36]. Lasco et al.
explored ATS use among disadvantaged men in the
Philippines and also found that participants described their
own use as managed and acceptable, drawing a clear dis-
tinction between being an ‘addict’ and a ‘user’ [59].
Social factors
Nine studies highlighted the perceived positive impact of
continued ATS use on friendships and relationships
[36,38,42,47,49,69,74,75], including Farrugia’s explora-
tion of how MDMA was used to facilitate a sense of inti-
macy between young male users [48]. Evidence also
emerged of a socially mediated level of ATS use being
established, with higher dosages than ‘acceptable’ within
friendship groups being stigmatized [59–61]. Linked to
thework performance issue highlighted previously, Bungay
et al. [41] examined ATS dependency among young adults
in urban Canada and found that motivations to continue
Figure 2 Coding of themes (no. of sources) presented by inﬂuencing sphere and critical change point [Colour ﬁgure can be viewed at
wileyonlinelibrary.com]
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use related to improved focus, particularly when commit-
ting acquisitive crime [41].
Environmental factors
Two studies found that street-entrenched and homeless
participants reported continued ATS use because of their
exclusion from more mainstream opportunity structures
such as stable housing, education and employment
[50,60]. Normalized ATS use in certain spaces and places
such as US college campuses [60], clubs and guest houses
[56] also contributed to continued consumption. Ambigu-
ity around the legal status of stimulant-type NPS also led to
their sustained use, fuelled by a perception of the reliable ef-
fects they produced [70].
Increase/relapse
Individual factors
A desire for heightened effects was identiﬁed as contribut-
ing to an increase in ATS use by both Boeri et al. [22]
and Eiserman et al. [47]. Loss of control of dosage and fre-
quency of methamphetamine-taking was cited by Haight
et al. as linked to increased use [53]. O’Brien et al. highlight
how such an increase often became part of a cycle of addic-
tion that users found difﬁcult to extricate themselves from,
particularly when their mental health and familial rela-
tionships had deteriorated [63]. Similarly, Boeri et al. [22]
reported that several critical events such unemployment,
loss of a relationship and lack of social support, could
coalesce, prompting an increase in methamphetamine
use, and subsequently a loss of control over dosage and
frequency [22].
Duff &Moore (2015) found that participantswere reluc-
tant to stopATSuse altogether because of persistingmental
health problems, underpinned byabelief thatmethamphet-
amine helped stabilize mood or feelings [46]. In Boeri et al.’s
US-based study, relapse after a period of abstinencewas pos-
ited as a ‘reward’ for good behaviour [22]. Bungay et al. also
report that temporary desistance from ATS for health
and/or aesthetic reasonswas framedas a short period of ‘de-
toxiﬁcation’ by some users, with consumption resumed
once health or desired weight was restored [41].
Social factors
Increased ATS use was also linked to social pressures. For
example, Fast et al. found that some street-entrenched
young adults wanted to avoid being stigmatized as a ca-
sual, inexperienced user (‘weekend warrior’) and so in-
creased their usage to boost their social status [50]. They
also found that people who had recently become homeless
reported rapid, intense ATS use as a way of socially inte-
grating with established networks. Loza et al. found that
ATS escalation became a practice which spread among so-
cial networks of women [73].
Work- and education-related factors also contributed to
increased ATS use. Von Mayrhauser et al. found that work
instability could motivate an escalation in use [71]; a point
echoed in studies from Boeri et al. [22] and German et al.
[51], alongside the impact of longer working hours.
Desantis et al.’s [44] research into the impact of ATS on
American students found that as they reached their ﬁnal
years, existing users would be more likely to escalate their
ATS use as a means of coping with increased stress around
exams andworkload [44] (a point reiterated by Kerley et al.
[57]). Three studies highlighted reconnecting to a former
drug-using network as contributing to relapse [22,38,51].
Environmental factors
Environmental and ecological stressors, such as unstable
housing, food and ﬁnances, were highlighted by O’Brien
et al. as causing increased ATS use [63]. Fast et al. focused
on the adverse impact of welfare withdrawal on depriva-
tion and disadvantage which, in turn, led to escalating
ATS use [49]. Bungay et al. found that a return to home-
lessness would lead to additional stressors, meaning that




A concern about physical and mental health was re-
ported as a factor stimulating desistence in fourteen
studies [30,40,41,47,50,51,54,55,60,61,64,66]. Fast
et al. found that the negative impact of heavy ATS use
on cognitive abilities, as well as increased paranoia and
deterioration of physical appearance, motivated partici-
pants to seek treatment [49]. Personal qualities such
as willpower and self-awareness were cited as further
factors supporting desistance in nine other studies
[22,41,45,47,49,51,54,56,76], as well as having experi-
enced negative effects from using poor quality ATS [65].
Social factors
Families and relationships could support or prompt
desistence in various ways. For example, Boeri et al. found
that the imminent threat of relationship breakdown
prompted ATS users to cease consumption [22]. Proximity
to an ATS-related death also emerged as a strong deterrent
in a study by Brown et al. [40]. More positively, both Green
et al. and German et al. found that the intervention of non-
using friends played an important part in helping ATS
users to abstain and in some cases seek treatment [51,52].
Changing or extricating themselves from particular so-
cial networks also appeared to support longer-term ATS
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abstention [38,39,63,66]. This also applied to the work-
place, as Lasco et al.’s study of young, disadvantaged male
ATS users in the Philippines found: some participants were
able to decrease or abstain from ATS usage as a result of
gaining licit employment, which provided routine and re-
spectability [59]. Similarly, Sexton et al. also highlight the
positive impactof licit employmentonreducedATSuse [66].
Environmental factors
A change in the legal status of ATS, particularly NPS, led to
desistence in a number of individuals in order to avoid in-
curring a criminal sanction [60]. Haight et al. also report
that imprisonment could have a positive impact on some
users’ capacity to desist from ATS use [53]. However, it
was unclear whether this pattern was maintained outside
of the prison environment.
DISCUSSION
This qualitative systematic review identiﬁed critical turn-
ing points on the ATS use trajectory [78]. We found a par-
ticularly rich literature describing accounts of initiation,
but less evidence on increasing or decreasing ATS use.
Throughout all turning points, family, friends and social
networks played a central role, facilitating users’ initial ac-
cess, as well as helping to normalize ATS consumption over
time. We also found that common individual, social and
ecological stressors contributed to changes in the trajec-
tory of ATS use [79]. Experiencingmental health problems,
relationship breakdown and social and economic exclusion
were strong themes at most time-points, with a number of
users experiencing such issues contemporaneously.
The relationship between mental health and ATS use is
complex. Experiencing stress, anxiety and/or depression
emerged as clear risk factors for ATS initiation, especially
methamphetamine, as well as making it more difﬁcult for
users to stop or reduce their consumption, an issue
highlighted in previous research [77,80]. Epidemiological
evidence also conﬁrms that psychostimulants are more
likely to induce psychosis than other illicit substances
[81], with depression, anxiety and suicidal ideation com-
monly co-occurring among methamphetamine users
[82]. However, it is also important to stress that the major-
ity of participants in the included studies were
polysubstance users, often consuming a variety of ATS
alongside other substances such as opioids and alcohol.
Whether cause or effect, the consequences for people
experiencing comorbid ATS use and mental health condi-
tions are profound, adversely affecting responses to treat-
ment and its outcomes [83–85].
ATS users are a highly diverse population, with study
participants encompassing students in higher education,
women carers and those in full-time work, as well as
highly marginalized groups such as sex workers, the
unemployed and homeless people [83]. The available data
limited our ability to identify trends within speciﬁc ATS
user groups. However, methamphetamine use was com-
mon among the most socially excluded communities
[22,38,41,49,50]. While 59% of studies were from the
United States (including all those examining misuse of
prescription stimulants), ATS use was global, and some
commonalities emerged. For example, boredom in rural
areas was seen as a factor contributing to ATS initiation
in both young men living in both South East Asia
[45,51,59,68,72] and North America [40]. However,
there were also some notable differences. Accounts of
ATS initiation in South East Asia focused on functional
methamphetamine use, to cope with the demands of
high-risk, often illicit employment, particularly sex work
[56,59,72]. In contrast, all the studies that explored rec-
reational ATS use, mostly ecstasy and NPS within the
club scene, were based in North America [36] Europe
[58,62,69] or Australia [52].
To our knowledge, this is theﬁrst reviewof international
qualitative literature on ATS use trajectories. As such, it re-
sponds to an identiﬁed gap in the empirical evidence base
on what shapes the course of ATS use over time [86]. A
strength of our review is the diverse and comprehensive
nature of the included studies, covering a variety of geo-
graphic, social and economic contexts, different drug use
practices and a range of user populations. However, our
ﬁndings are limited by the quality of the available literature,
with the majority of included papers deemed of moderate
quality. We chose to retain two papers classed as of low
quality in our synthesis, as despite the lack of detail on re-
cruitment, ethics and researcher-reﬂexivity, the studies pro-
vided valuable data on particularly marginalized ATS user
populations in the case of Ho’s study of female sex workers
[56], or employed a novel conceptual framework to explore
ATS use, as in Brown’s exploration of masculinity in Amer-
ican methamphetamine users [40]. Moreover, thematic
synthesis is deemed appropriate when such variability ex-
ists in the richness and ‘thickness’ of data [87].
Few papers focused on stimulant-based NPS, probably
reﬂecting their relative recency, as well as the challenge
of capturing this rapidly shifting area of substance use
[88–90]. Further, we found little qualitative evidence ex-
ploring users’ perspectives on which factors enabling de-
creased ATS use or longer-term abstinence, although
previous systematic reviews have considered the clinical ef-
fectiveness of potential interventions for ATS dependency
[12,19,20]. Data on environmental shaping of ATS use at
potential change points was also scarce. However, users
in the included studies often found it challenging to isolate
precise points at which levels of use increased or decreased,
which could in turn make it difﬁcult to identify external or
distal factors contributing to these changes in their drug
use pathway.
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Several implications for policy and practice emerge
from this review. By identifying which factors contribute
to speciﬁc transitions in an individual’s ATS use trajectory,
our ﬁndings highlight windows of opportunity for inter-
vention, as well as providing contextual information
shaping the change points. Such evidence could contrib-
ute to more effective targeting of harm reduction and
treatment efforts. Based on previous research, we would
suggest that there is particular demand for swift and re-
sponsive services for adolescent users, where progression
from recreational to dependent levels of consumption
can occur within a short time-frame [91]. Further, as
others have found, high-risk sexual behaviour appears
common among ATS users [92], meaning that sex risk
reduction measures, such as condom provision and vol-
untary HIV counselling/testing, are also needed [93,94].
Next, the heterogeneous nature of ATS users suggests
the need for treatments and interventions that are tailored
to speciﬁc subgroups. For example, there are gender differ-
ences in the epidemiology, patterns and consequences of
substance use, as well as treatment outcomes [95]. We
would therefore suggest that future policy builds on posi-
tive evidence for the incorporation of gender-speciﬁc ele-
ments into treatment programmes [95] and the
effectiveness of integrated programmes for women with
children [96]. Similarly, given that mental health was iden-
tiﬁed as a common factor contributing to the initiation and
escalation of ATS consumption, there is a need to address
the mental health needs of users in order to improve treat-
ment outcomes [97].
Lastly, while certain subgroups need tailored interven-
tion packages, our ﬁndings also highlight the need for
joined-up care from service providers to address users’
overlapping health, welfare and social care needs
[19,98,99]. There is substantial evidence that drug-
dependent individuals are likely to have frequent and often
sustained interactions with criminal justice, social service
and both primary and secondary health-care systems
[100–102], yet policy responses are too often fragmented
and uncoordinated [103,104]. Stopping ATS use was re-
ported as particularly challenging, and often required users
to extract themselves from former social networks to de-
crease or cease consumption. We would suggest that ther-
apeutic interventions that help users to accumulate
increased social capital, including access to broader social
networks, are more likely to support their longer-term
transition into abstinence [105].
CONCLUSIONS
The ﬁndings from this review underline the heterogeneous
nature of ATS users, and the complicated dynamic of indi-
vidual, social and environmental factors that shape differ-
ent consumption trajectories. Alongside developing
interventions better tailored to themultiple, complex needs
of speciﬁc user subgroups, future research should explore
which factors support reduced consumption or abstinence
over the longer term.
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